{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:12Z","timestamp":1790371032601,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pneumocystis pneumonia (PCP) is an opportunistic, infectious disease that is prevalent in immunosuppressed hosts. Corticosteroid treatment is the most significant risk factor for patients with PCP who are human immunodeficiency virus negative, although little is known about how corticosteroids alter the host defense against Pneumocystis infection. In the present study, we used transcriptome analysis to examine the immune response in the lungs of corticosteroid-treated PCP mice. The results showed down-regulation in the genes related to both native immunity, such as antigen processing and presentation, inflammatory response, and phagocytosis, as well as B and T lymphocyte immunity. The repression of gene expression, corresponding to B cell immunity, including B cell signaling, homeostasis, and Ig production, was prominent. The finding was confirmed by quantitative PCR of mouse lungs and the peripheral blood of patients with PCP. Flow cytometry also revealed a significant depletion of B cells in corticosteroid-treated PCP mice. Our study has highlighted that corticosteroid treatment suppresses the B cell immunity in the PCP host, which is likely one of the main reasons that corticosteroid treatment may stimulate PCP development.<\/jats:p>","DOI":"10.1165\/rcmb.2015-0356oc","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T13:23:54Z","timestamp":1477574634000},"page":"322-331","source":"Crossref","is-referenced-by-count":29,"title":["Transcriptomic Analysis Reveals Significant B Lymphocyte Suppression in Corticosteroid-Treated Hosts with\n                    <i>Pneumocystis<\/i>\n                    Pneumonia"],"prefix":"10.1093","volume":"56","author":[{"given":"Yang","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine and Critical Care Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Critical Care Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Critical Care Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"2026021122415619100_bib1","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1001\/jama.2009.880","article-title":"Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment","volume":"301","author":"Kovacs","year":"2009","journal-title":"JAMA"},{"key":"2026021122415619100_bib2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"2026021122415619100_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jiac.2014.03.003","article-title":"Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients","volume":"20","author":"Kofteridis","year":"2014","journal-title":"J Infect Chemother"},{"key":"2026021122415619100_bib4","doi-asserted-by":"crossref","first-page":"e101943","DOI":"10.1371\/journal.pone.0101943","article-title":"Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"key":"2026021122415619100_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2026021122415619100_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/en.2012-2045","article-title":"New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor\u2013mediated transactivation","volume":"154","author":"Vandevyver","year":"2013","journal-title":"Endocrinology"},{"key":"2026021122415619100_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12364","article-title":"Unraveling the functions of the membrane-bound glucocorticoid receptors: first clues on origin and functional activity","volume":"1318","author":"Strehl","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"2026021122415619100_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1: Multicenter Aids Cohort Study Group","volume":"322","author":"Phair","year":"1990","journal-title":"N Engl J Med"},{"key":"2026021122415619100_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7326\/0003-4819-111-3-223","article-title":"CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection","volume":"111","author":"Masur","year":"1989","journal-title":"Ann Intern Med"},{"key":"2026021122415619100_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/fmb.09.116","article-title":"Current understanding of Pneumocystis immunology","volume":"5","author":"Kelly","year":"2010","journal-title":"Future Microbiol"},{"key":"2026021122415619100_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1128\/iai.24.3.939-947.1979","article-title":"Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice","volume":"24","author":"Walzer","year":"1979","journal-title":"Infect Immun"},{"key":"2026021122415619100_bib12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI13826","article-title":"CD4+ T cell\u2013independent vaccination against Pneumocystis carinii in mice","volume":"108","author":"Zheng","year":"2001","journal-title":"J Clin Invest"},{"key":"2026021122415619100_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1189\/jlb.1207816","article-title":"Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand\u2013deficient mice","volume":"84","author":"Hernandez-Novoa","year":"2008","journal-title":"J Leukoc Biol"},{"key":"2026021122415619100_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4049\/jimmunol.1500112","article-title":"B lymphocytes are required during the early priming of CD4+ T cells for clearance of Pneumocystis infection in mice","volume":"195","author":"Opata","year":"2015","journal-title":"J Immunol"},{"key":"2026021122415619100_bib15","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/IAI.00744-13","article-title":"B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice","volume":"81","author":"Opata","year":"2013","journal-title":"Infect Immun"},{"key":"2026021122415619100_bib16","doi-asserted-by":"crossref","first-page":"e78699","DOI":"10.1371\/journal.pone.0078699","article-title":"Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy","volume":"8","author":"Migita","year":"2013","journal-title":"PLoS One"},{"key":"2026021122415619100_bib17","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1084\/jem.20060221","article-title":"Ig\u03b2 tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization","volume":"203","author":"Gazumyan","year":"2006","journal-title":"J Exp Med"},{"key":"2026021122415619100_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.imlet.2010.09.001","article-title":"The role of Ig-\u03b1\/\u03b2 in B cell antigen receptor internalization","volume":"134","author":"Jang","year":"2010","journal-title":"Immunol Lett"},{"key":"2026021122415619100_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2012.11.019","article-title":"The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor\u2013mediated signaling","volume":"38","author":"Mattila","year":"2013","journal-title":"Immunity"},{"key":"2026021122415619100_bib20","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1073\/pnas.1117374108","article-title":"Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival","volume":"109","author":"Zikherman","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021122415619100_bib21","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood-2011-01-332106","article-title":"CXCL13\/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics","volume":"118","author":"S\u00e1ez de Guinoa","year":"2011","journal-title":"Blood"},{"key":"2026021122415619100_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201444971","article-title":"B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis","volume":"45","author":"Br\u00fchl","year":"2015","journal-title":"Eur J Immunol"},{"key":"2026021122415619100_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/IR:31:2:119","article-title":"CD19 function in central and peripheral B-cell development","volume":"31","author":"Del Nagro","year":"2005","journal-title":"Immunol Res"},{"key":"2026021122415619100_bib24","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4049\/jimmunol.1202098","article-title":"Reduced T-dependent humoral immunity in CD20-deficient mice","volume":"191","author":"Morsy","year":"2013","journal-title":"J Immunol"},{"key":"2026021122415619100_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/intimm\/dxq055","article-title":"B-cell homeostasis requires complementary CD22 and BLyS\/BR3 survival signals","volume":"22","author":"Smith","year":"2010","journal-title":"Int Immunol"},{"key":"2026021122415619100_bib26","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4049\/jimmunol.177.5.3063","article-title":"CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo","volume":"177","author":"Haas","year":"2006","journal-title":"J Immunol"},{"key":"2026021122415619100_bib27","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.173.4.2245","article-title":"TNF family member B cell\u2013activating factor (BAFF) receptor\u2013dependent and \u2013independent roles for BAFF in B cell physiology","volume":"173","author":"Sasaki","year":"2004","journal-title":"J Immunol"},{"key":"2026021122415619100_bib28","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2006-10-051847","article-title":"Endogenous bcl-2 is not required for the development of E\u03bc-myc\u2013induced B-cell lymphoma","volume":"109","author":"Kelly","year":"2007","journal-title":"Blood"},{"key":"2026021122415619100_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ni925","article-title":"Bcl11a is essential for normal lymphoid development","volume":"4","author":"Liu","year":"2003","journal-title":"Nat Immunol"},{"key":"2026021122415619100_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","article-title":"Pneumocystis pneumonia in patients treated with rituximab","volume":"144","author":"Martin-Garrido","year":"2013","journal-title":"Chest"},{"key":"2026021122415619100_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/IAI.67.2.805-809.1999","article-title":"Intranasal immunization confers protection against murine Pneumocystis carinii lung infection","volume":"67","author":"Pascale","year":"1999","journal-title":"Infect Immun"},{"key":"2026021122415619100_bib32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.70.3.1069-1074.2002","article-title":"Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia","volume":"70","author":"Gigliotti","year":"2002","journal-title":"Infect Immun"},{"key":"2026021122415619100_bib33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/IAI.74.1.390-393.2006","article-title":"Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia","volume":"74","author":"Wells","year":"2006","journal-title":"Infect Immun"},{"key":"2026021122415619100_bib34","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.171.3.1423","article-title":"Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii\u2013specific antibody","volume":"171","author":"Lund","year":"2003","journal-title":"J Immunol"},{"key":"2026021122415619100_bib35","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/IAI.03099-14","article-title":"Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia","volume":"83","author":"Elsegeiny","year":"2015","journal-title":"Infect Immun"},{"key":"2026021122415619100_bib36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/rccm.201401-0171OC","article-title":"Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock","volume":"189","author":"Wong","year":"2014","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/56\/3\/322\/66830704\/ajrcmb_56_3_322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/56\/3\/322\/66830704\/ajrcmb_56_3_322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T03:47:48Z","timestamp":1770868068000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/56\/3\/322\/8467347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,1]]},"published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2015-0356oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,3]]},"published":{"date-parts":[[2017,3,1]]}}}